OTU deubiquitinases in disease: roles and targeting.
Dysregulation of protein homeostasis contributes to many human diseases and is an emerging therapeutic target.
APA
Deng Y, Liu P (2026). OTU deubiquitinases in disease: roles and targeting.. Trends in molecular medicine, 32(1), 84-97. https://doi.org/10.1016/j.molmed.2025.05.006
MLA
Deng Y, et al.. "OTU deubiquitinases in disease: roles and targeting.." Trends in molecular medicine, vol. 32, no. 1, 2026, pp. 84-97.
PMID
40527635
Abstract
Dysregulation of protein homeostasis contributes to many human diseases and is an emerging therapeutic target. Proteasome-mediated degradation requires ubiquitin tagging, a process regulated by E3 ligases and reversed by deubiquitinases (DUBs). Among DUBs, the ovarian tumor protease (OTU) family exhibits poly-ubiquitin linkage-specific activity and regulates diverse cellular processes. OTU dysregulation has been linked to diseases such as cancer, highlighting their potential as drug targets. This review summarizes current knowledge of OTU functions, regulatory mechanisms, and disease associations, as well as therapeutic strategies targeting OTUs. By examining these aspects, we aim to provide insights into the pathophysiological roles of OTUs and support ongoing efforts to develop OTU-targeted therapies for human diseases.
MeSH Terms
Humans; Deubiquitinating Enzymes; Animals; Neoplasms; Molecular Targeted Therapy; Ubiquitination
같은 제1저자의 인용 많은 논문 (5)
- Multi-dimensional analysis reveals the potential of PDK4 as a tumor biomarker and target for immunotherapy.
- Mechanism of d-Glucaro-1,4-lactone enhancing the anticancer efficacy of lenvatinib via the IFN-γ-STAT3-PD-L1 signaling pathway in hepatocellular carcinoma.
- Bioresponsive immunomodulator nanocomplex for selective immunoengineering in metastatic lymph nodes.
- DNAJB6 as an immuno-oncogenic hub in liver hepatocellular carcinoma: multi-omic profiling reveals prognostic significance and therapeutic vulnerability.
- Association between frailty and the risks of chronic pulmonary diseases and lung cancer.